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STUDIES ON INFLUENZA VIRUS RECEPTOR SUBSTANCE AND
RECEPTOR-SUBSTANCE ANALOGUES
II. Isolation and Purification of a Mucoprotein Reoeptor Substance from
Human Erythrocyto Stroma Treated with Pentanot
Agglutination of red cells by influenza virus, and the concept of "receptor"
areas on the cell surface which are enzymatically modified after contact with
virus, were described by Hirst in 1942.17 Since that time much indirect
evidence has been collected suggesting that virus receptors consist, at least
in part, of mucoid substances; examples of this evidence are the inactiva-
tion of receptors by periodate1' and the active competition with receptors
by mucoids such as the "Francis inhibitor" of serum and ovarian cyst
fluids,'" ovomucin,14"' and highly purified sheep salivary mucoid.'
Direct isolation of specific receptor-substance mucoids from the complex
lipoprotein of the erythrocyte surface is obviously more difficult than the
purification of receptor analogues from soluble mucoid secretions. Virus-
inhibitory extracts have, however, been prepared from red cells of various
species by boiling stroma in water"5 or by extracting red cells in a Waring
blendor.' A purified preparation isolated from human red cell stroma in the
first instance as an ether-soluble lipomucoid was described in 1948 by
deBurgh, Yu, Howe, and Bovarnick.' Their most active fraction contained
at least 50%o reducing substances but was said to contain neither hexosa-
mine nor phosphorus. In the same year Woolley'1 obtained a heat-labile
polysaccharide substance from the supernatant fluid of hemolyzed erythro-
cytes which was shown to antagonize the antihemagglutinin effect of apple
pectin. After exposure to influenza virus the purified erythrocyte substance
was no longer capable of inhibiting pectin, and it was concluded that the
former material, which itself showed detectable inhibition of PR8 virus at
0.04 ,ug/ml.," was the substrate for enzymic attack by virus on the red cell
surface. In an extensive study by Howe,1' which appeared while the present
work was in progress, physical methods were described for the isolation
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by high-speed centrifugation at controlled pH and ionic strength, of
stroma fractions rich in virus inhibitor and blood-group substance. In the
majority of these cases, however, detailed chemical investigations of the
various preparations were not described.
Although we have found the method of deBurgh et al. relatively con-
venient to carry out in the laboratory, the yield of active material is ex-
tremely low, and, even after further purification, the most active fraction is
markedly inhomogeneous in the ultracentrifuge.' We have also prepared an
active virus-inhibitory lipomucoid by extracting dried red cells with dilute
ethanol, as originally described by Hallauer16 for the isolation of blood-
group substance, but the method is cumbersome and the yield is again
extremely small. It has seemed desirable, therefore, to investigate alterna-
tive methods in an attempt to improve the yield and, if possible, the
homogeneity, of extracted receptor-substances.
In the present investigation, human red-cell stroma were treated with
pentane in the hope that active material might be released into the solvent.
Neither virus-inhibitor nor blood-group substance were, however, present
in the pentane extract, but it was observed that after treatment with this
solvent at room temperature for several days the stroma were converted
into a stable amorphous gel. It seemed likely that stroma in this finely
divided state would be suitable for further extraction, and it was subse-
quently found that relatively large amounts of active material passed into
solution when the stroma gel was extracted with 50%o ethyl alcohol. No
active material was obtained if stroma were extracted without the pre-
liminary pentane treatment.
This paper describes some of the properties of a virus-inhibitory muco-
protein obtained in relatively high yield from human group A stroma
treated by the pentane-dilute alcohol process. The mucoprotein has been
examined chemically and in the ultracentrifuge and electrophoresis appara-
tus. The inhibitory activity of the various mucoprotein fractions has been
estimated against several active and indicator strains of influenza virus, and
the destruction of inhibitory activity confirmed on exposing purified
receptor-substance to active influenza virus or the receptor enzyme of
V. cholerae.
MATERIALS AND METHODS
Virus. "Reference" strains of influenza A and B virus, in the form of infected
allantoic fluid, were obtained through the kindness of Doctor Alick Isaacs of the
World Influenza Centre, Mill Hill, London. "Indicator" forms of strains LEE, MEL,
and PR8 (i.e., H.LEE, H.MEL, and H.PR8) were prepared by heating the allantoic
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fluids at 370 or 55° C. under the conditions described by Stone." Virus in this form is
considerably more sensitive to inhibition by mucoids than active (unheated) virus."
Receptor-destroyer enzyme. A purified preparation of V. cholerae receptor-destroying
enzyme was kindly provided by Sir Macfarlane Burnet. The material had been purified
as described by Ada and French.1
Titration of viral antihemagglutinin. The method employed throughout these studies
was essentially that described by Anderson.' In summary, a series of double dilutions
of the extracts was prepared in 0.2 ml. of normal saline; ten agglutinating units of
virus in the same volume of saline were then added to each, and the mixture held at
40 C. for one hour. Finally, 0.2 ml. of a freshly prepared 1% suspension of pigeon or
"sensitive" fowl erythrocytes were added, and the pattern of agglutination read 1 to
1 /2 hours later. In the majority of cases pigeon cells were used since they possess the
added advantages of rapid settling and high stability as well as giving titres of the
same order as the most sensitive fowl cells. The titres obtained with the pigeon
erythrocytes from our stock did not vary significantly from bird to bird.
Particular care was taken to standardize the titrations of inhibitory activity as far
as possible, since the subsequent procedures were to a large extent conditioned by them.
A "standard" preparation was included in all tests, and the titrations of any one series
of fractions were carried out at the same time with the same virus suspension. The
latter was titrated immediately before use, diluted to give ten agglutinating doses per
unit volume, and the titre of the dilute preparation checked against the freshly pre-
pared red-cell suspension. The relatively powerful dose of ten units was used through-
out because it was observed in earlier experiments with red-cell extracts that there is
not necessarily an inverse relation between virus dose and inhibitory titre over the
lower range of virus concentration. With a low virus dose, e.g. two agglutinating
units, partial inhibition may be observed to a relatively high titre and a sharp end-
point is difficult to obtain. A similar phenomenon has been observed by Doctor C. M.
Chu (personal communication 1950) with "normal" inhibitor in mouse sera against
certain influenza virus strains.
Titration of blood-group activity. These titrations were carried out with standard
human anti-A sera according to the usual agglutination-inhibition technique.'m
Analytical methods. Nitrogen was determined by the micro-Kjeldahl method using
the apparatus of Markham; P by the method of Briggs' reducing sugar by the method
of Somogyi," N-acetyl-hexosamine and hexosamine by a modification of the methods
described by Morgan and Elson" and Elson and Morgan,' respectively, and methyl
pentose by the method of Dische and Shettles' using a "Uvispek" spectrophotometer.
Paper chromatography for amino acids was carried out according to the methods
described by Consden, Gordon, and Martin' and for sugars and hexosamines as
described by Partridge.' The aniline hydrogen phthalate reagent" was used for identi-
fying sugars. All chromatograms were run on Whatman No. 4 paper, the solvents
being s-collidine, butanol-acetic acid, and phenol-ammonia.
Stroma. Stroma were prepared from washed human group A red cells by precipita-
tion in the cold at pH 5.6 as described by Jorpes.' Packed stroma, prepared in batches
of approximately 200 ml., were stored at -10° C. until 1-2 liters had been accumulated.
They were then thawed, pooled, and treated as described in the following sections.
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EXPERIMENTAL
Preparation A 1. Stromata (1 liter) was added to 2 liters of pentane with
vigorous stirring. The emulsion was shaken for several hours daily for four
weeks and then passed through a Sharples Supercentrifuge; the superna-
tant fluid, which contained neither virus inhibitor nor blood-group sub-
stance, was discarded. The deposited stroma gel was collected and resus-
pended in 2 liters of pentane, shaken for a further ten days, and again
passed through the Supercentrifuge. The stroma gel, which still contained
a considerable amount of pentane, was suspended in 2.5 liters of 50% alco-
hol. After shaking for several hours, a finely divided stable colloidal dis-
persion was formed, which, after standing for 14 days, was passed four
times through the Sharples centrifuge. The clear, orange-colored superna-
tant fluid (extract A 1-1) was concentrated to small volume in vacuo and
stored at -10° C. The stroma deposit, resuspended in 2 liters of 50%o
alcohol, was again extracted for seven days and then passed through the
centrifuge as before (extract A 1-2). The concentrated supernatant fluids
were freeze-dried, extracted with absolute alcohol in a Soxhlet apparatus,
and washed with ethanol, alcohol-ether, and acetone: yield, 33.3 gm. from
extract A 1-1 and 4.2 gm. from extract A 1-2. The stroma residue was
again extracted with 10% alcohol for several days, but no further active
material was recoverable.
Preparation A 2. Pooled stromata (2 liters) was shaken for three weeks
with 9 liters of pentane and the gel-like mass extracted successively with
15 liters (extract A 2-1) and 12 liters (extract A 2-2) of 50%o alcohol over
a period of several weeks. The supernatant fluids were concentrated in
vacuo to approximately 300 ml. and centrifuged on the "Servall" angle
centrifuge at 8,000 r.p.m. to remove any finely divided insoluble particles.
Active virus-inhibitory material was precipitated from the slightly
opalescent supernatant fluids as described below.
ETHANOL FRACTIONATION OF THE EXTRACTS
Preparation A 1. The first freeze-dried extract (A 1-1) was taken up in
400 ml. of water, stirred for one hour, and centrifuged. The active material
was precipitated from the supernatant fluid by the addition of 900 ml. of
ethanol in the presence of potassium acetate. After dialysis and freeze-
drying 3.3 gm. of brown powder were obtained. A second fraction, col-
lected by increasing the ethanol concentration to 80%o, consisted of dark
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brown tarry inactive material. The second extract (A 1-2) was fractionated
with ethanol at the same level, yielding 0.7 gm. of dark brown powder.
Preparation A 2. Ethanol (1 liter) was added with stirring in the
presence of potassium acetate to 700 ml. of the pooled concentrated extract
A 2-1. The heavy flocculent precipitate was collected on the centrifuge,
washed twice with 90%o ethanol, and dried in vacuo-weight 43 gm. Ex-
tract A 2-2 was similarly treated with 1.8 volumes of ethanol and yielded
3.2 gm. of dark brown material. All the antihemagglutinin activity was
recovered in these precipitates.
TABLE 1. ANALYSIS AND VIRUS INHIBITORY ACTIVITY OF FOUR STROMA
FRACTIONS PRECIPITATED WITH ETHANOL
Analysis Inhibitory activity
Material N% P% Hexosamine %o* H.LEEt H.MELt
Fraction Al-I 9.1 1.5 10.0 1200 1280
Fraction A1-2 10.1 1.5 8.8 2000 2560
Fraction A2-1 9.6 1.0 10.0 1000 1280
Fraction A2-2 10.5 0.7 10.6 1200 1800
* Calculated as glucosamine-HCl.
t Titre of 1% solution against 10 units of indicator LEE virus.
t Titre of 1% solution against 10 units of indicator MEL virus.
Analytical figures for the four alcohol-precipitated fractions are given in
Table 1, together with inhibitory activities against two indicator virus
strains. It will be seen that the nitrogen content of the four preparations is
reasonably uniform, varying from 9.1 in A 1-1 to 10.5 in A 2-2. All contain
both hexosamine and phosphorus in contrast to the findings of deBurgh
et al.' for ether-extracted receptor-substance. In our hands, however, prepa-
rations made by the ether-extraction process at a comparable stage of purity
contained 3.4% N, 5.6%o hexosamine, and 1.3% P.tm Active fractions iso-
lated by differential centrifugation contained 8-13%1o N and 1-1.5o P.19 All
four preparations inhibit hemagglutination by indicator LEE and MEL
viruses to equivalent titres, the second of each pair of fractions tending to
be more active than the first against both virus strains. As has been
observed with most partially purified erythrocyte extracts, indicator MEL
virus is inhibited to higher titre than indicator LEE, although in this case
the difference is relatively small.
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As the various fractions were similar in composition and activity, the
three main ones (A 1-1, A 1-2, and A 2-1) were mixed, resuspended in
750 ml. of 50%'o ethanol, shaken at intervals for ten days, centrifuged, and
the insoluble residue again extracted with 50% ethanol three times. The
alcoholic extracts were pooled, centrifuged at 8,000 r.p.m. for 30 minutes,
and the clear, straw-colored supernatant fluids concentrated in vacuo and
dried from the frozen state. The material (6.8 gm.) was completely dis-
solved in 70 ml. of distilled water, and two volumes of ethanol were added
cautiously at 00 C., a trial fractionation on a small aliquot having shown
that the active component precipitated uniformly between 1.25 and 1.75
volumes of ethanol. The flocculent precipitate was collected on the cen-
trifuge, redissolved in water, dialyzed against several changes of distilled
water for 48 hours at O° C., and finally freeze-dried. The yield was 2.8 gm.
of very pale yellow material (AP-1).
At this stage the titre of a 1% solution of the partially purified muco-
protein was 4,800 against H.LEE and 3,500 against H.MEL. Considerable
loss of activity had, therefore, occurred during the later stages of the purifi-
cation process, since the weight of active material had been reduced from
41 gm. to 2.8 gm. with only an approximately two-fold increase in activity.
Further, antihemagglutinin titre against H.MEL was now slightly lower
than against H.LEE. Purification was continued, however, since the rigor-
ous chemical treatment was designed to obtain a homogeneous preparation
rather than one of exceptional inhibitory activity.
Treatment with acid alcohol-ether. A portion (2 gm.) of fraction AP-1
was dissolved in 40 ml. of distilled water and added drop by drop to 200 ml.
of 60-40 alcohol-ether containing 0.5%o hydrochloric acid and maintained
at -40' C.' Stirring was continued for four hours, after which time the
insoluble material was removed by centrifugation at 0° C. and redissolved
in 30 ml. of cold distilled water. The extraction process was then twice
repeated. Finally, the extracted material was dialyzed against several
changes of distilled water at 40 C., spun in the angle centrifuge at 8,000
r.p.m. for 30 minutes, and freeze-dried. The final product (AP-2) weighed
1.6 gm. The virus-inhibitory activity was not reduced by this treatment.
Treatment with the Sevag technique. A portion (0.5 gm.) of fraction
AP-2 was exhaustively treated by a modified Sevag deproteinization
process. The material was dissolved in 50 ml. of 0.2 M acetate buffer at
pH 5.7 and stirred vigorously with 20 ml. of chloroform-butanol for one
hour. The white colloidal deposit of denatured protein was removed by
centrifugation, and the process continued until no further protein came out
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of solution. Approximately 15 treatments were required. The supernatant
fluid was then dialyzed free from buffer at 40 C. and freeze-dried, yielding
120 mg. of pure white material which dissolved rapidly to give a colorless,
faintly opalescent solution. The denatured protein was shaken for several
days in a large volume of buffer, centrifuged, and the supernatant fluid
dialyzed and freeze-dried; 102 mg. of whitish powder was so obtained.
A second 0.5 gm. portion of AP-2 was treated in the same way with the
exception that the pH of the acetate buffer was 6.7 instead of 5.7.
TABLE 2. ANALYSIS OF ERYTHROCYTE MUCOPROTEINS AFTER TREATMENT
WITH THE MILES-PIRIE AND SEVAG TECHNIQUES
Reducing
Fraction NS P 5%* sugart Hexosaminet
Pool-AP-2 10.0 0.46 2.6 14.7 9.5
Sevag treatment 5.3 - - 13.7 6.3
Sevag treatment residue 7.7 - - 11.0 7.3
* Determined by Drs. Weiler and Strauss, Oxford.
t Hydrolysed with 0.5 N HC1 for 24 hours; calculated as glucose.
1 Hydrolysed as above; calculated as glucosamine-HCl.
- Not determined.
CHEMICAL PROPERTIES OF THE ISOLATED MUCOPROTEINS
All the fractions obtained in these experiments were readily and com-
pletely soluble in water. Before Sevag treatment, fraction AP-2 became
faintly opalescent on the addition of an equal volume of 10%o trichloracetic
or sulphosalicylic acids. There was no precipitation on boiling or on adding
picric or phosphotungstic acids, but slight precipitation occurred with 5%o
tannic acid and there was heavy precipitation with basic lead acetate. The
biuret and ninhydrin tests were positive. After Sevag treatment the opales-
cence on adding trichloracetic and sulphosalicylic acids was very faint, but
the other properties remained unaltered.
The analytical figures for the products obtained after extraction with acid
alcohol-ether (AP-2), and after treatment by the Sevag technique, are
given in Table 2.
Comparison with the analytical figures obtained for the earlier fractions
(Table 1) shows that, as would be expected, the alcohol-ether treatment
significantly reduced the P content without altering the other figures. The
hexosamine: N ratio remained approximately 1: 1. After the Sevag treat-
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ment at pH 5.7, however, the N content was reduced by almost 50%o but
the hexosamine: N ratio was only slightly increased at 1: 1.2.
As described in a later section, an active (cathode) fraction was sepa-
rated from the Sevag-treated material by electrophoresis; the analytical
figures for this fraction were N, 6.3%o, reducing sugar, 15.3%o, and hexosa-
mine, 7.4%o. The hexosamine: N ratio of 1: 1.18 was, therefore, not sig-
nificantly different from that of the Sevag-treated material before being
submitted to electropho-
0 resis.
A small amount of
firmly bound lipid re-
7S .|/HEX XOSAMIN Kmained even after re-
peated acid alcohol-ether REDUCING SUBSTANCES extraction. This could be
Jfi ( demonstrated by hydro-
I- DU - 1 'lyzing the extract with
0.5N hydrochloric acid
or N acetic acid for eight
hours and then extract-
ing the hydrolysate sev-
eral times with three
volumes of ether and
1,.. pentane. After evapora-
1 3 s r 7 11 13 95 17 o
HYDROLYSIS TIME IN HOURS tion, a small amount of
FIG. 1. Release of reducing substances and hexo- fatty residue, equivalent
samine from erythrocyte fraction AP-2 heated at t 4
1000 C. with 0.5N HCl. to 47o of the original
material, was recovered
from the organic solvents. The nature of this lipid has not been investigated
further.
Hydrolysis curve. The liberation of reducing substances and hexosamine
during hydrolysis of fraction AP-2 was followed by sealing aliquots of a
1%o solution in small glass ampoules with 0.5N hydrochloric acid, and
immersing in a boiling water bath. Ampoules were removed at intervals
and the contents carefully neutralized with sodium hydroxide. Typical
results are illustrated in Figure 1. It will be seen that both reducing sub-
stances and hexosamine are released very rapidly under these conditions;
the maximum value for reducing sugar is reached at 24 hours and for
hexosamine at 17 hours. A considerable amount of charring takes place
during hydrolysis with hydrochloric acid, and also, though to a lesser
extent, with sulphuric or acetic acids.
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Chromatographic examination of hydrolysate. The hydrolysis products
were examined for reducing sugars, hexosamines, and amino acids by
means of paper partition chromatography. In preliminary experiments con-
siderable difficulty was encountered with severe "trailing," particularly
when the papers were sprayed with the aniline hydrogen phthalate reagent
for sugars. This difficulty was partly, though not entirely, overcome by the
following technique: 10-20 mg. of fraction AP-2 were hydrolyzed overnight
in 5N or 0.5N hydrochloric acid, and the hydrolysate then extracted twice
with three volumes of ether and once with three volumes of pentane. "Trail-
ing" was less marked when the more concentrated acid was used for
hydrolysis. After centrifugation, the water layer was evaporated to dryness
in a vacuum desiccator over sulphuric acid and caustic soda. The residue
was taken up in one ml. of distilled water, approximately three mg. of
Norite charcoal added, and the mixture brought to boiling point for one
minute. After filtration the crystal-clear filtrate was again taken to dryness
in vacuo. The residue, taken up in a small volume of water, was then
applied to the paper strips and runs carried out in s-collidine, butanol-
acetic acid, and phenol-ammonia with a minimum of "trailing." In one
experiment the ether-extracted hydrolysate was passed through columns of
the ion-exchange resins "Deacidite" and "Amberlite 1RC-50H" instead of
being heated in the presence of charcoal, but the chromatographic results
were inferior to those obtained after charcoal treatment.
In the final runs, two aliquots of hydrolysate were run on each paper
together with "known" mixtures of galactose, glucose, glucosamine-
hydrochloride, and chondrosamine-hydrochloride. The papers were then cut
in two, one half being sprayed with the aniline hydrogen phthalate reagent,
and the other half with the hexosamine reagents. Two pink spots with RF
values equal to those of the "known" glucosamine and chondrosamine
hydrochlorides were obtained in collidine, and two similar but poorly sepa-
rated spots in butanol-ammonia; a single spot only was obtained in phenol.
The addition of glucosamine and galactosamine to the hydrolysate increased
the intensity of the hexosamine spots, but no additional spots appeared.
In all solvents definite spots were found with RF values corresponding
to galactose and fucose, respectively. A further faint spot with the same RF
as glucose was also observed, but as the color was distinctly different, the
identity of this spot is still doubtful.
Chromatograms were also run for amino-acids after hydrolysis in 6N
hydrochloric acid. Ten spots were obtained on spraying with the ninhydrin
reagent, corresponding to lysine, arginine, glycine, alanine, proline, valine,
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leucine, and phenylalanine. Chondrosamine and glucosamine were also
identifiable on these chromatograms.
Solubility in liquid phenol and diethylene glycol. The mucoprotein
(fraction A 2-1) was completely soluble in 95% liquid phenol. A 1: 1
mixture of liquid phenol and ethanol was cautiously added to the solution,
but only approximately 10%o of the material was precipitated when the
ethanol concentration reached 50%o. The activity of this precipitated frac-
tion was slightly less than that of the
48 R original mucoprotein. Fractions pre-
4_ cipitated above 50%'o ethanol concen-
*E 40 - \ tration were largely insoluble in
%-.# 36 ' water. The exceptionally high solubil-
> 32 - ity of the mucoprotein in liquid phe-
z 28 - nol is paralleled by the behavior of
z24 § the sheep salivary mucoprotein.'
- 20 The erythrocyte mucoprotein was
z 16 also completely soluble in diethylene x 2X glycol, a solvent used extensively for
8 hx the purification of bacterial mucopro-
4 teins. After high-speed centrifugation
and passage through a Berkefeld
220 200 250 260 270 280 290 300 candle, the clear solution was frac-
WAVELENGTH (rn/A) tionated with ethanol at various levels
FIG. 2. Ultraviolet absorption spec- between 30% and 80%o final concen-
trum of fraction AP-2 (0.04% aqueous tration. A small amount of material
solution).
only was precipitated up to the 40%o
level, and fractions precipitated above this level were completely inactive.
From these experiments it was clear that neither phenol nor diethylene
glycol could be used in further purification of receptor-substance muco-
proteins.
PHYSICAL PROPERTIES OF THE MUCOPROTEIN
Ultra-violet absorption spectrum. The ultra-violet absorption of fraction
AP-2 was examined in the "Uvispek" spectrophotometer, using a one cm.
cell and an 0.04%o solution in distilled water. The curve (Fig. 2) shows a
broad, ill-defined peak extending over the range 245-280 m,u. It is probable
that the absorption at 245-260 m,u represents nucleoprotein; absorption
from 270-280 m,u is probably due to aromatic amino acids.
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Sedimentation.* A 1%o solution of extract AP-2 before and after Sevag
treatment was examined in the ultracentrifuge at pH 8 in phosphate buffer
(I = 0.1 + 0.15M NaCI) and at pH 4 in acetate buffer. The material
sedimented very slowly at both pH 4 and 8, showing a fairly well-defined
single symmetrical peak with little evidence of polydispersion. The peak
appeared rather more sharply defined after Sevag treatment (Fig. 3).
Electrophoresis.* One per cent solutions of fraction AP-2 before and
after Sevag deproteinization were examined at pH 4 and 8 in the Tiselius
apparatus. Before deproteinization, three broad, ill-defined components were
(b6) FIG. 4. Electrophoresis
diagram of lo solution
FIG. 3. Sedimentation diagram of 1% solutions of of fraction AP-2 after
fraction AP-2; (a) before Sevag treatment; (b) Sevag treatment. Phos-
after Sevag treatment. Phosphate buffer pH 8, I = phate buffer pH 8, I =
0.1 + 0.15M NaCl. Exposures taken 40 min. after 0.2. Exposure taken after
reaching full speed, 60,000 r.p.m. (240,000 G). separation for 300 mAH.
observed. Two well-defined and widely separated peaks were observed after
Sevag treatment (Fig. 4). It was possible to separate these peaks in the
electrophoresis apparatus, and, as shown in the following section, activity
was associated with the larger slower-moving component only.
BIOLOGICAL PROPERTIES OF THE EXTRACTED MUCOPROTEINS
Virus inhibition spectrum. The "inhibition spectrum" of various fractions
against a range of indicator and active influenza virus strains is given in
Table 3.
Fraction AP-2 (pooled fractions soluble in 50%o ethanol, after extraction
with acidified alcohol-ether), showed the highest virus-inhibitory activity of
all fractions obtained in the present experiments. The titre of 10,000 against
indicator LEE was comparable to that of purified serum mucoid fractions,'
but considerably lower than the activity of purified mucoproteins isolated
from sheep salivary glands.' The titre of fraction AP-2 against H.LEE
actually increased after treatment with alcohol-ether, a phenomenon not yet
* These procedures were carried out through the kindness of Dr. R. A. Kekwick.
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explained, but observed also with serum mucoid'2 and erythrocyte mucopro-
teins extracted in ether. A significant increase in inhibitory activity was
observed against all indicator virus strains as compared to active (un-
heated) virus: in the case of LEE and indicator LEE an approximately
20-fold increase occurred with each fraction shown in the table. Another
point to be noted is that, with these preparations, the titre against H.MEL
was lower than that against H.LEE.
In contrast to the result expected from previous experience with receptor
analogues, very extensive loss of inhibitory activity against all strains
occurred after Sevag treatment at either pH 5.7 or 6.7: the titre against
H.LEE, for example, was reduced to approximately 20%o of the original
TABLE 3. ANTIHEMAGGLUTININ ACTIVITY OF 1% SOLUTIONS OF
ERYTHROCYTE MUCOPROTEINS BEFORE AND AFTER SEVAG TREATMENT
Fraction LEE H. LEE MEL H. MEL PR8 H. PR8
Pool-AP-2 500 10,000 500 4,000 800 3,200
Pool-Sevag treated pH 5.7 10 1,750 10 100 10 10
Pool-Sevag residue pH 5.7 500 9,000 100 4,000 700 2,800
Pool-Sevag treated pH 6.7 100 2,800 10 600 80 300
Pool-Sevag residue pH 6.7 180 9,600 10 2,800 750 2,400
figure, and the activity against other strains was decreased to an even
greater extent. Thus, after treatment at pH 5.7, none of the active strains
were demonstrably inhibited, nor was H.PR8. As found with other
erythrocyte extracts, activity against active MEL and H.PR8 is particu-
larly sensitive to destruction during chemical treatment, while that against
H.LEE is the most stable. At pH 6.7 some activity remained against active
LEE and PR8, and against H.PR8, but it is clear that even the relatively
milder conditions have brought about severe loss of inhibitory activity. It
should be noted, however, that the soluble mucoprotein extracted from the
precipitated protein gel resulting from the Sevag treatment showed activity
of similar order to that of the original material (before Sevag treatment)
against strains LEE, H.LEE, H.MEL, PR8, and H.PR8, but again the
titre against MEL was significantly reduced.
Effect of electrophoresis. The virus-inhibitory activity of the two electro-
phoretically separated components from the Sevag fraction treated at pH
5.7 is given in Table 4.
The results obtained for the electrophoretically separated components are
of considerable interest. The small anode component (Fig. 4) was com-
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pletely inactive toward all strains, but the larger, slower-moving cathode
peak was associated with the slightly higher activity against H.LEE than
was the starting material. It is clear, however, that complete concentration
of activity against this strain has not been achieved, since the cathode com-
ponent represents only 5%o of the total material (100 mg.) subjected to
electrophoresis.
Inactivation by influenza virus and RDE. Sufficient data may be given
here to show that the inhibitory action of the purified erythrocyte extract is
progressively lost on incubation with living influenza virus or the "receptor-
destroying" enzyme of V. cholerae' as has previously been described for
purified ovarian cyst mucoid6 and purified sheep salivary mucoid.' More
TABLrE 4. VIRus INHIBITORY ACTIVITY OF ELECTROPHORETICALLY
SEPARATED ERYTHROCYTE FRACTIONS
Fraction LEE H.LEE MEL H.MEL
Sevag treatment pH 5.7 <10 1,750 <10 100
Cathode component <10 2,500 <10 <10
Anode component <10 <10 <10 <10
detailed studies now in progress on the kinetics of inactivation with a series
of virus strains will be described in a later paper.
Aliquots of a solution of purified erythrocyte extract (AP-2) were
incubated with 100 agglutinating units of fresh LEE or MEL virus diluted
in acetate buffer pH 6.4 containing 0.1%o CaCl2. Control tubes with heat-
inactivated virus and without virus were included. After two hours' incuba-
tion at 370 C. the tubes were removed from the bath and brought to 1000 C.
for one minute to destroy the active virus. It was found that active LEE
virus reduced antihemagglutinin activity against H.LEE to 30%o and
against H.MEL to less than 1% of the control values. Active MEL virus
reduced the titres against the two strains by 50% and 70%o respectively.
Aliquots of purified erythrocyte extract were also incubated with a puri-
fied eluate of V. cholerae receptor-destroying enzyme (RDE) diluted in
calcium acetate buffer pH 6.4. After incubation at 37° C. for two hours
with an equal volume of a 0.005%o solution of RDE, a solution of erythro-
cyte extract showing originally a titre of 6,000 against H.LEE and 4,000
against H.MEL had become completely inactive (less than 1: 10) against
both strains.
Inactivation by periodic acid. Like the red cell receptore8 and the soluble
Francis inhibitor in normal serum and purified serum mucoidu the inhibi-
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tory activity of the purified erythrocyte extract is sensitive to the periodate
ion. Exposure of a 1% solution of fraction AP-1 in acetate buffer at pH
5.0 to 0.005M periodic acid for one hour at room temperature reduced the
titre (H.LEE) from 9,600 to 10.
Action of trypsin. A 0.5% solution of purified fraction AP-2 was incu-
bated for two hours with an equal volume of 2%o "Difco" trypsin in borate
buffer pH 8.1, controls containing heat-inactivated enzyme being included.
No significant reduction in titre occurred against LEE, H.LEE, MEL,
or H.MEL.
Blood-group activity. The anti-A and anti-H activity of the extracts was
estimated at various stages during the fractionation process. No anti-A
activity was detected in the crude extracts, and only minimal (less than
1: 10) inhibition of anti-H sera. The purified fraction AP-1 was kindly
examined in detail by Miss Joan Thompson, who reported no inhibition
(less than 1: 2) of anti-B, anti-M, or anti-D sera, and inhibition titres of
64 and 512 against anti-H and anti-A sera respectively.
DISCUSSION
The receptors of influenza virus exist on the erythrocyte surface presum-
ably as part of a lipomucoid complex. The first stage of the chemical
isolation of receptor-substance in methods so far described involves pre-
liminary treatment with a concentrated lipid solvent which releases part of
the complex in an extractable form; this is achieved in the process of
deBurgh et al.' by heating (or freezing and thawing) stroma with ether,
and with dried red cells by prolonged extraction with 95%o alcohol.16 It is
probable that in both these processes only a small fraction of the total
receptor-substance is released from the stroma."9 Further purification in all
processes depends essentially on removal of firmly bound lipid from the
extracted lipomucoid and fractionation of the protein components.
The chief advantages of the pentane-dilute alcohol process described in
this paper are, first, the virtual absence of blood-group activity which is
constantly associated with erythrocyte extracts prepared by the ether
extraction of stroma or alcohol extraction of freeze-dried red cells"9"'; and,
secondly, the isolation of a product which is completely and rapidly soluble
in water and which retains constant activity even after storing in the dry
state for up to two years. In our hands, erythrocyte extracts prepared by
other methods frequently become partially insoluble after storage in vacuo
and may also become largely insoluble after storing in solution at -10° C.
for several days. This applies particularly to preparations made by the
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ether-extraction process. The final yield of active substances with the pen-
tane method is considerably greater than with the alcohol extraction of
freeze-dried cells or with the ether extraction of stroma. It is clear, how-
ever, that none of the chemical methods so far described for preparing
receptor-substance even approaches the ideal.
The presence of two hexosamines in the erythrocyte mucoprotein seems
established on chromatographic evidence. Two spots with RF values equal
to those of glucosamine and galactosamine were invariably found, and no
further spots appeared when the two known hexosamines were added to
the hydrolyzate. However, definitely to establish the identity of the two
hexosamines it would be necessary to isolate crystalline derivatives from
large amounts of extract-a procedure which has not yet been possible. In
this connection it may be noted that the single hexosamine present in sheep
salivary mucoid was found to have the same RF value as galactosamine in
various solvents, but the melting point of the dinitrophenyl derivative was
distinctly lower than that of the authentic galactosamine compound.' The
presence of galactose seems reasonably certain; this sugar has been found
in all erythrocyte extracts so far examined. It is probable that galactose
occurs in small amounts only, since the spots obtained were weak, usually
fainter than those of fucose. The presence of fucose, which is found in small
amounts in all red cell extracts so far examined, was confirmed both by
chromatography and the spectrophotographic method. It is of interest that
the electrophoretically homogeneous mucoprotein of human urine,' which
also actively inhibits influenza virus hemagglutination, contains glucosa-
mine, galactosamine, galactose, mannose, and fucose.14'
The question of homogeneity of this, and in fact in all preparations of
large molecules, is a difficult one; electrophoresis and ultracentrifugation
provide some evidence of the range of variation in mobility and molecular
size, but one is always faced with the possibility of dealing with mixtures
of molecules of different biological specificity which show similar physical
behavior in an electrical or sedimentation field. The present preparation
shows a single peak even after prolonged sedimentation in the ultracen-
trifuge, little evidence of polydispersion, and extremely slow sedimentation,
thus indicating the presence of small molecules of the same order of size:
the molecular weight is probably less than 87,000 since the erythrocyte
mucoprotein moves more slowly than the homogeneous mucoprotein iso-
lated from sheep salivary glands.' The electrophoretic pattern before Sevag
treatment is a complicated one with at least three differnt components;
after Sevag treatment two sharp, well-separated peaks are obtained, inhibi-
tory activity (against H.LEE) being associated with the considerably
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larger slow-moving peak only. In this instance, therefore, an electro-
phoretically and ultracentrifugally homogeneous mucoprotein has been
isolated from erythrocytes with moderate antihemagglutinin activity against
one virus strain.
The extensive and unexpected loss of activity against all virus strains
after mild Sevag treatment is difficult to interpret. In previous studies on
the serum mucoid "Francis inhibitor" it had been found that antihemag-
glutinin activity against H.LEE was lost only if Sevag treatment was
carried past a certain stage, but that activity against certain influenza A
strains ("non-specific inhibitor") was destroyed very rapidly. These find-
ings, together with other differences, were considered by McCrea' to estab-
lish the non-identity of the Francis and non-specific inhibitors, the former
being associated with serum mucoid and the latter with the more labile
serum proteins. This problem has also been discussed by other workers
(e.g. Smith, Wilson, and Westwood'5) who consider that it is more prob-
able that the two inhibitors exist as different components of one complex. It
is possible that Sevag treatment in the present instance has inactivated one
part of a large molecule (that part inhibiting active and indicator A strains)
while leaving the more stable component inhibiting H.LEE relatively intact.
The experimental evidence obtained in the present investigation is against
this interpretation, however, since quantitative recovery against the other
strains (with the exception of MEL) was obtained from the deposited pro-
tein gel. Thus, it would appear that a separation of a nonprecipitated
H.LEE inhibitory component has been obtained, and not simply inactiva-
tion of one component or group of components in a complex molecule. It
will be noticed that the active material washed out from the protein gel
resulting from Sevag treatment is similar in composition to the fraction
remaining in solution (Table 2), the hexosamine: N ratio being practi-
cally unchanged. This suggests that one is dealing with a mixture of chemi-
cally very closely related mucoproteins, the chief distinction being that the
inhibitor of H.LEE is less readily precipitated by chloroform.
The virus "inhibitor spectrum" of the pooled material, before Sevag
treatment, is H.LEE > H.MEL > H.PR8 > PR8 > LEE=MEL. In the
majority of erythrocyte extracts prepared by other methods, inhibitory titre
against H.MEL is approximately twice as high as against H.LEE, the
reversal in the present instance probably being a reflection of the rigorous
chemical treatment. In the "crude" extract from pentane-treated stroma
the titre against these two indicator strains is scarcely significantly different.
It is perhaps impossible to compare the activities of erythrocyte extracts
prepared by different methods, since the relative degree of purity is difficult
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to assess; however, a 1% solution of the most active mucoprotein fraction
isolated by the ether-extraction process inhibits H.LEE to a titre of 16,000
and H.MEL to 56,000; the corresponding figures for the most active
alcohol-extract from dried red cells are 8,000 and 16,000 respectively.' The
pentane preparation, therefore, shows intermediate activity against H.LEE
but is less active than those isolated by other methods against active and
indicator A strains.
As would be expected, the isolated receptor-substance is inactivated after
contact with living virus or with the bacterial receptor-enzymes. Inactiva-
tion by virus is slower than has been found with other erythrocyte prepara-
tions, a finding which will be discussed in detail in a later publication
dealing with the interaction of virus and isolated red-cell receptor sub-
stances. The resistance to inactivation by trypsin should be mentioned here,
however, since Hirste8 stated that trypsin destroyed receptors on the
erythrocyte, although in preliminary work on receptor-destroying enzymes
we had not found this to be so.7"'' The experimental details in Hirst's paper
are not entirely clear, however, no indication of enzyme concentration or
time of incubation being given. In cases where trypsin enzymically inacti-
vates receptor analogues such as sheep salivary mucoid, it does so at
extremely high dilution.' None of the erythrocyte extracts we have pre-
pared are significantly affected even on incubation with 1% trypsin for
several hours. Howe' found that the antihemagglutinin activity of a "lipid-
rich" stroma fraction resisted proteases, but a "lipid-poor" fraction was
susceptible to chymotrypsin.
Finally, the relatively slight blood-group activity of this preparation is
noteworthy, since all other erythrocyte extracts prepared in our laboratory
show high activity toward the specific group from which the cells are
derived, and also with regard to the heterogenetic "H" blood-group sub-
stance.' The specific blood-group activity of the purified pentane-treated
extract is at most only 2%b, and the "H" substance activity is considerably
less than 1%, of the titres shown by erythrocyte preparations obtained by
ether or alcohol extraction without preliminary pentane treatment (W. T. J.
Morgan and W. M. Watkins, in preparation). From the data at present
available it is difficult to decide whether preliminary pentane treatment
degrades and inactivates blood-group substance, or whether this solvent,
which appears to facilitate the release of virus receptor-substance, actually
"fixes" blood-group substance to the stroma in a form which is not extract-
able in 50%o alcohol. A similar finding with freeze-dried red-cells treated
with pentane will be described in the next paper in this series. The choice of
solvent used in the preliminary extraction obviously is of great importance
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in attempting to obtain receptor-substance free from blood-group substance,
since in no case has it proved possible chemically to separate the two sub-
stances when both are present in the one solution.
SUMMARY
A method is described for the isolation of influenza virus "receptor-
substance" from human erythrocytes. Red cell stroma were shaken with
pentane to form a colloidal gel from which the active substance was
extracted in 50%o ethanol.
A stable virus-inhibitory mucoprotein has been obtained which was
completely soluble in water, 95%o phenol, and diethylene glycol. The ana-
lytical figures were: N 10.0%o, P 0.5%o, S 2.6%o, reducing sugar 14.7%o,
and hexosamine 9.5%o. Chromatography revealed the presence of two
hexosamines (probably glucosamine and galactosamine), galactose, fucose,
and amino acids. Approximately 4%o of ether-soluble lipid was released on
hydrolysis with acid. The ultraviolet absorption spectrum suggested the
presence of nucleic acid.
One very slow-moving component with only slight evidence of polydis-
persion was found in the ultracentrifuge. At least three components
appeared on electrophoresis. After deproteinization by the Sevag technique,
two sharply defined peaks were found on electrophoresis, the larger and
slower-moving one alone being associated with virus inhibitory activity
against indicator LEE virus.
A 1l%o solution of the extract inhibited hemagglutination by heated LEE
virus to a titre of 10,000. The inhibition "spectrum" was H.LEE >
H.MEL > H.PR8 > PR8 > LEE=MEL. After Sevag treatment
approximately 80% of the activity against H.LEE and practically all activ-
ity against active and indicator A strains was removed from solution.
Inhibitory activity against all strains, with the exception of MEL, could,
however, be quantitatively recovered from the deposited protein-muco-
protein gel.
Capacity to inhibit virus hemagglutination was lost when the mucoprotein
was incubated with active virus, or with the receptor enzyme of V. cholerae.
Incubation with 1%o trypsin did not significantly reduce the antihemag-
glutinin activity.
The blood-group activity of the mucoprotein was at most only a few per
cent of that found in extracts prepared by other methods.
The relation of this mucoprotein to those prepared from erythrocytes by
alternative methods, and to soluble "receptor analogues," is briefly
discussed.
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